Media Centre
AstraZeneca Q1 2018 Results
AstraZeneca will announce its Q1 2018 Results at 07:00 GMT on Friday 18th May 2018. You are invited to participate in a media conference webcast or conference call, hosted by CEO Pascal Soriot, starting at 09:00 GMT.
Conference detailsLatest press releases
-
Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease
-
The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer
-
Lynparza in combination with abiraterone delayed disease progression in metastatic castration-resistant prostate cancer
-
Moxetumomab pasudotox pivotal data in patients with previously-treated hairy cell leukaemia presented at the 2018 ASCO Annual Meeting
-
Update on TERRANOVA Phase III trial for Fasenra in chronic obstructive pulmonary disease
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
